| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9267204 | Joint Bone Spine | 2005 | 5 Pages |
Abstract
Conclusions. - In refractory rheumatoid arthritis patients, the addition of infliximab therapy may result in clinical, laboratory and magnetic resonance imaging improvement. Magnetic resonance imaging assessment of the volume of the enhancing inflammatory tissue may represent an additional tool for the investigation of joint disease activity and responsiveness to treatment.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Immunology, Allergology and Rheumatology
Authors
Maria I. Argyropoulou, Anastasia Glatzouni, Paraskevi V. Voulgari, Vassilios G. Xydis, Spyros N. Nikas, Stavros C. Efremidis, Alexandros A. Drosos,